WE-REACH

March 26, 2020

WE-REACH Executive Director Talks Covid-19 with USA Today, Salon, and Geekwire

Dr. Rodney Ho, the Principal Investigator (PI) and Director of the Center for WE-REACH talked with USA TodaySalon, and Geekwire to discuss remdesivir, lopinavir, and hydrocholoroquinine as potential treatments for Covid-19.

As part of the center’s focus on providing scientists a bridge to medical impact, WE-REACH has prepared a list of funding opportunities with the NIH. For additional opportunities, see WE-REACH partner ITHS.